U.S. National Cancer Institute perspective on precision oncology
6 Jul 2018
U.S. National Cancer Institute perspective on precision oncology
WINTHER & SPRING: Targeted agents and triple agent combinations
MyPathway study: a novel precision oncology multiple basket trial
Implementing precision medicine in oncology: The IMPACT trials
Precision CAR T cell therapeutics
Lessons from long-term survey of stage I NSCLC
The latest understanding of breakthrough cancer pain management
Editor's Choice for June 2018
Expert insight: The basic medical understanding of neutropenia and general clinical considerations
MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs
CDK6 a transcriptional regulator in AML
ASCO 2018 conference round up